Skip to content

ΕτικέταSpark Therapeutics

Spark’s Hemophilia A Gene Therapy Significantly Reduced Bleeding in Clinical Trial

An investigational gene therapy treatment for hemophilia A has seen a 97 percent response rate after one treatment for the 12 trial participants, Spark Therapeutics announced this morning. The company said it intends to … Continue Reading Spark’s Hemophilia A Gene Therapy Significantly Reduced Bleeding in Clinical Trial